本页面由Tiger Trade Technology Pte. Ltd.提供服务

Collegium Pharmaceutical, Inc.

47.91
+0.48001.01%
成交量:27.48万
成交额:1,307.42万
市值:15.14亿
市盈率:29.48
高:47.92
开:47.59
低:46.81
收:47.43
52周最高:48.37
52周最低:23.23
股本:3,161.10万
流通股本:2,809.02万
量比:0.53
换手率:0.98%
股息:- -
股息率:- -
每股收益(TTM):1.63
每股收益(LYR):2.14
净资产收益率:22.96%
总资产收益率:6.75%
市净率:5.51
市盈率(LYR):22.35

数据加载中...

2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/08/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/07

重要事件披露

Form 8-K - Current report
2025/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/07

重要事件披露

Form 8-K - Current report
2025/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/06

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/06

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/06

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments